The UK government has secured 150,000 doses of the mpox vaccine from Bavarian Nordic to strengthen its defenses against the virus, prioritizing individuals at higher risk of exposure. The move comes as the World Health Organization (WHO) declared mpox a global health emergency, with a significant surge in cases, particularly in the Democratic Republic of Congo.
With the first case of Monkeypox reported in India, concerns about the spread of the disease have risen. While experts emphasize the need for vigilance, they also highlight that the disease is less fatal than COVID-19 and the risk of a pandemic seems low. This article explores the symptoms, transmission, and precautions related to Monkeypox.
Applied DNA Sciences, through its subsidiary Applied DNA Clinical Labs (ADCL), has expanded its clinical testing services for mpox, leading to a 37% surge in its stock price. The new service now includes detection of both Mpox Clade I and Clade II, aiming to bolster efforts to combat the rising mpox threat.
India has reported its first confirmed case of mpox virus in a 26-year-old man who recently returned from abroad. The patient is currently stable and the case is being managed according to established protocols. While the strain detected is not the current cause of global concern, the situation is being closely monitored.
Africa is facing a major mpox outbreak, with over 25,000 cases and 643 deaths reported in 2024. However, high vaccine costs are hindering efforts to contain the spread, leaving many African nations reliant on donations. The situation underscores the urgent need for affordable and accessible vaccines to protect vulnerable populations.
India has issued a nationwide alert after its first suspected case of Mpox was reported in Delhi. The Centre has instructed states and union territories to screen, test, and trace contacts of all suspected cases, while also identifying isolation facilities for both suspected and confirmed patients. This comes after the World Health Organization declared Mpox a Public Health Emergency of International Concern in August 2024.
Moderna’s mRNA-1769 vaccine demonstrated superior protection against mpox in monkeys compared to the currently available Jynneos vaccine, offering hope for a more effective vaccine against this emerging disease.
The Democratic Republic of Congo (DRC) received its first shipment of mpox vaccines, marking a significant step in combating the ongoing outbreak. The delay in vaccine delivery highlights the persistent issue of vaccine access disparities in low- and middle-income countries, mirroring the challenges encountered during the COVID-19 pandemic.
Indonesia has introduced a new health pass requirement for all incoming travelers, aimed at curbing the spread of the Mpox virus. The SATUSEHAT Health Pass, a mandatory electronic self-declaration form, must be completed within 48 hours prior to arrival. This initiative reflects Indonesia’s commitment to public health and its efforts to prevent potential outbreaks. The country has also strengthened its healthcare infrastructure and vaccine stockpiles to manage Mpox cases effectively.
The Democratic Republic of Congo received its first shipment of mpox vaccines on Thursday, marking a significant step in combating the ongoing outbreak. This comes after the World Health Organization declared the mpox outbreaks in 12 African countries a global health emergency. The vaccines, donated by the European Union, are expected to help address the inequity in access to vaccines between African nations and wealthier countries.
